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ABSTRACT The trimeric human single-stranded DNA-
binding protein (HSSB; also called RP-A) plays an essential
role in DNA replication, nucleotide excision repair, and
homologous DNA recombination. The p34 subunit ofHSSB is
phosphorylated at the G1/S boundary of the cell cycle or upon
exposure of cells to DNA damage-inducing agents including
ionizing and UV radiation. We have previously shown that the
phosphorylation of p34 is catalyzed by both cyclin-dependent
kinase-cyclin A complex and DNA-dependent protein kinase.
In this study, we investigated the effect of phosphorylation of
p34 by these kinases on the replication and repair function of
HSSB. We observed no significant difference with the un-
phosphorylated and phosphorylated forms of HSSB in the
simian virus 40 DNA replication or nucleotide excision repair
systems reconstituted with purified proteins. The phosphor-
ylation status of the p34 subunit of HSSB was unchanged
during the reactions. We suggest that the phosphorylated
HSSB has no direct effect on the basic mechanism of DNA
replication and nucleotide excision repair reactions in vitro,
although we cannot exclude a role of p34 phosphorylation in
modulating HSSB function in vivo through a yet poorly
understood control pathway in the cellular response to DNA
damage and replication.
The human single-stranded DNA (ssDNA)-binding protein
(HSSB; also called RP-A) is essential for DNA replication and
nucleotide excision repair and may play important roles in
recombination and transcription (1-6). The protein is made up
of polypeptides of 70, 34, and 14 kDa; the human genes
encoding the three subunits have been cloned, and the com-
plex has been assembled from vectors expressing all three
subunits in Escherichia coli (7) as well as in baculovirus-
infected cells (8). The function of HSSB has been extensively
studied in the simian virus 40 (SV40) DNA replication system
where it has been shown that all three subunits are essential for
replication. The p70 subunit binds ssDNA, whereas the func-
tions of the other subunits are unknown, though antibodies
against any one of the subunits have been shown to inhibit
SV40 DNA replication (9-11). The subunit structure of HSSB
is highly conserved in eukaryotes. In Saccharomyces cerevisiae
each of the ssDNA-binding protein subunits is encoded by a
single essential gene (12).
The p34 subunit of HSSB becomes phosphorylated at the
G1/S boundary of the cell cycle (13) and upon exposure of cells
to DNA damage by ionizing (14) or UV (15) radiation. These
observations have led to speculation that the phosphorylation
state of the protein modulates its function in DNA replication
and repair. In support of this model, it has been reported that
extracts from UV-irradiated HeLa cells contained almost
exclusively the hyperphosphorylated form of HSSB and were
incapable of supporting SV40 DNA replication (15) and that
the addition of the unphosphorylated form of HSSB restored
the replication activity to the cell extract. DNA damage
induces the cyclin-dependent kinase (cdk) inhibitor p21 (Cip
1, WAF 1, or Sdi 1), which binds proliferating cell nuclear
antigen (PCNA) and inhibits SV40 DNA replication (16, 17)
but apparently not nucleotide excision repair (18, 19). These
findings suggested the following cellular response to DNA
damage. The DNA lesions lead to formation of a PCNA-p21
complex and phosphorylation of HSSB, which inhibits chro-
mosomal DNA replication but allows DNA repair to occur.
After repair is completed, sufficient quantities of free PCNA
and unphosphorylated HSSB are generated to enable normal
progression through the cell cycle. We wished to test this
model and, in particular, to investigate whether or not phos-
phorylation of the p34 subunit of HSSB played a role in
coordinating DNA repair with replication during the cell cycle.
We used the in vitro SV40 DNA replication system (20-22)
to investigate the effect of HSSB phosphorylation on DNA
replication and the recently developed reconstituted human
nucleotide excision repair system (6) to study its effect on DNA
repair. Both replication and excision reactions are absolutely
dependent on HSSB. We found that the unphosphorylated and
phosphorylated derivatives of HSSB were equally active in
supporting replication and repair. While these observations do
not exclude a possible role of the phosphorylated HSSB in vivo,
they do not support a direct link between phosphorylation of
HSSB and a coordinated response linking replication inhibi-
tion to increased repair activity.
MATERIALS AND METHODS
Preparation of Phosphorylated and Unphosphorylated
HSSB. HSSB (0.42 mg), purified from cytosolic extracts of
HeLa cells as described (9), was added to a reaction mixture
(5.6 ml) containing 40 mM creatine phosphate (pH 7.7),
creatine kinase (25 /ag/ml), 7 mM MgCl2, 0.5 mM dithioth-
reitol (DTT), 4 mM ATP, G1 extract (21.8 mg), and cyclin A
(0.23 mg). The preparation of G1 extracts from HeLa cells and
cyclin A was as described (23). After incubation at 37°C for 1
hr, the mixture was adjusted to 0.2M NaCl, 20mM EDTA, 0.5
mM DTT, 1 mM phenylmethanesulfonyl fluoride, antipain (2
jug/ml), leupeptin (1 Lg/ml), 1 mM Na3VO4, 10mM NaF, and
0.1 ,M okadaic acid and then loaded onto a phosphocellulose
Abbreviations: ssDNA, single-stranded DNA; HSSB, human ssDNA-
binding protein; DNA-PK, DNA-dependent protein kinase; DTT,
dithiothreitol; SV40, simian virus 40; PMSF, phenylmethanesulfonyl
fluoride; AS, ammonium sulfate; PCNA, proliferating cell nuclear
antigen; cdk, cyclin-dependent kinase; T antigen, SV40 large tumor
antigen
tZ.-Q.P. and C.-H.P. contributed equally to this work.
§To whom reprint requests should be addressed.
4636
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement" in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 92 (1995) 4637
column (4 ml) equilibrated with buffer B [25mM Tris-HCl (pH
8.0), 1 mM EDTA, 0.01% Nonidet P-40, 10% (vol/vol)
glycerol, 1 mM DTT, 0.1 mM phenylmethanesulfonyl fluoride,
antipain (0.2 uLg/ml), and leupeptin (0.1 ,Lg/ml)] plus 0.2 M
NaCl. The column was washed with 4 ml of buffer B containing
0.2 M NaCl and phosphatase inhibitors (1 mM Na3VO4, 10
mM NaF, and 0.1 ,LM okadaic acid). The flow-through and
wash fractions were pooled, adjusted to 0.5 M NaCl, and then
chromatographed on a ssDNA-cellulose column (0.5 ml)
equilibrated with buffer B plus 0.5 M NaCl. After washing with
10 ml of buffer B plus 0.7 M NaCl, bound protein was eluted
with 2 ml of buffer B plus 2 M NaCl and 45% (vol/vol) ethylene
glycol. The eluate was dialyzed against 1 liter of buffer B plus
0.25 M NaCl for 2 hr at 0°C and subsequently concentrated by
centrifugation using a Centriflow-25 cone (Amicon). This
procedure yielded 64 ,Ig of phosphorylated HSSB (1.6 mg/ml).
As a control for experiments, HSSB was prepared using the
same procedure as described above except that ATP, creatine
kinase, and MgCl2 were omitted from the reaction mixture.
The procedure yielded 53 ,pg of unphosphorylated protein (1.5
mg/ml). This material is referred to as (mock-treated) un-
phosphorylated HSSB. HSSB purified from cytosolic extracts
of HeLa cells (9) and used for the preparation of phosphor-
ylated HSSB is referred to as untreated HSSB.
In Vitro SV40 DNA Replication Assays. SV40 DNA repli-
cation with the monopolymerase system was carried out as
described (24). Reaction mixtures (40 /ul) contained 40 mM
creatine phosphate (pH 7.7), creatine kinase (25 pLg/ml), 7mM
MgCl2, 0.5 mM DTT, 4mM ATP, 200 p.M other rNTPs, 20 puM
[a-32P]dCTP (-5000 cpm/pmol), 100 p.M other dNTPs, 10 .Lg
of bovine serum albumin, 0.3 ptg of pSVAEP ori+ DNA, 1200
units of topoisomerase I, the DNA polymerase a-primase
complex (1.2 and 1.6 units, respectively), 0.6 p.g of SV40 large
tumor antigen (T antigen), and HSSB in either the unphos-
phorylated or phosphorylated form, as indicated. After incu-
bation at 37°C for 2 hr, the radioactive, acid-insoluble material
was measured.
SV40 DNA replication, using the ammonium sulfate (AS)
fraction-complementation system, was carried out as described
(20). Reaction mixtures (40 ptl) contained 40 mM creatine
phosphate (pH 7.7), creatine kinase (25 gug/ml), 7 mM MgCl2,
0.5 mM DTT, 4 mM ATP, 200 ,pM other rNTPs, 20 /xM
[a-32P]dCTP (-18,000 cpm/pmol), 100 p.M other dNTPs, 0.3
,tg of pSVAEP ori+ DNA, 0.6 p.g of T antigen, 35-65% AS
fraction (152 ,ug), and HSSB in either the unphosphorylated or
phosphorylated form, as indicated. After incubation at 37°C
for 1 hr, the radioactive acid-insoluble material was measured.
In Vitro Excision Assays. The excision assay (25) used
measured the release of a 28-mer carrying a lesion from a
140-bp duplex containing 32p label at the 54th phosphodiester
bond and cholesterol instead of a base at position 70, located
6 nucleotides 3' to the label. The reaction mixture (50 ,1l)
contained 40 mM Hepes (pH 7.9), 80 mM KCI, 8 mM MgCl2,
2 mM ATP, 20 /LM each dNTP, bovine serum albumin (100/ug/ml), 1 mM DTT, 1 nM 32P-labeled substrate, 7% glycerol,
fractions I-IV (xeroderma pigmentosum A-G plus TFIIH) as
reported previously (6), and the indicated amounts of fraction
V (HSSB), either in the unphosphorylated or phosphorylated
form. The reaction mixture was incubated at 30°C for the
indicated time, and the products were analyzed on a 10%
polyacrylamide sequencing gel as described (6). The yield of
excision product was quantified using a PhosphorImager (Mo-
lecular Dynamics). The excision was expressed as the fraction
of total radiolabel migrating in the 25- to 28-nucleotide area.
RESULTS
Analysis of Phosphorylated HSSB. We previously demon-
strated that the p34 subunit of HSSB is phosphorylated in
cyclin A-activated G1 extracts by cdk-cyclin A and DNA-
dependent protein kinase (DNA-PK; ref. 23). To analyze the
effects of phosphorylation of HSSB on SV40 DNA replication
and nucleotide excision repair, we isolated the phosphorylated
form of HSSB after incubating HSSB with cyclin A-activated
G1 extracts and an ATP-regenerating system, as described in
Materials and Methods. This procedure quantitatively con-
verted the p34 subunit of HSSB to phosphorylated products
(Fig. 1, lane 2) that included at least four different species
migrating more slowly through denaturing polyacrylamide gels
than the mock-treated HSSB (unphosphorylated form, lane 3)
and the HSSB isolated from HeLa cells (untreated, lane 1).
The phosphorylated p34 derivatives have been shown to result
from the combined action of highly purified cdk-cyclin A and
the Ku antigen-stimulated DNA-PK (ref. 23; H. Niu, Z.-Q. P.,
and J.H., unpublished results).
Effects of Different Forms of HSSB on SV40 DNA Repli-
cation. We examined the effects of phosphorylation of HSSB
on SV40 DNA replication using two different assays. As
previously described (24), SV40 DNA replication can be
carried out by the monopolymerase system in which both
leading- and lagging-strand DNA synthesis are catalyzed by
high levels of the DNA polymerase a-primase complex. In
addition to the DNA polymerase a-primase complex, this
system requires SV40 ori+ DNA, T antigen, topoisomerase I,
and HSSB. We have previously shown that components of the
monopolymerase system are both necessary and sufficient to
initiate RNA primer synthesis and that HSSB is specifically
required for this reaction (26, 27). For these reasons, we
compared unphosphorylated and phosphorylated HSSB for
their ability to support the monopolymerase system. As shown
in Fig. 2A, these two forms of HSSB, as well as HSSB isolated
from HeLa cells, were equally active except that at low levels
(<100 ng), the phosphorylated HSSB was about 2-fold more
active than the unphosphorylated form.
The replication activity of HSSB was also tested using an AS
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FIG. 1. Denaturing polyacrylamide gel (SDS/PAGE) analysis of
unphosphorylated and phosphorylated HSSBs. Purified HSSB (2 jAg)
either untreated (lane 1) or treated with cyclin A-activated G1 extracts
in the presence (lane 2) or absence (lane 3) of ATP was analyzed by
SDS/12.5% PAGE and Coomassie brilliant blue staining. Protein size
markers (in kDa) are shown on the left. The bracketed region indicates
the slow-migrating phosphorylated forms of the p34 subunit. The
protein band migrating between 70 and 43 kDa reacted with anti-p70
antibody and is most likely a degradation product of p70.
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FIG. 2. Effects of HSSB phosphorylation on SV40 DNA replica-
tion with the monopolymerase system (A) and the 35-65% AS fraction
complementation assay (B). Replication assay conditions are de-
scribed in Materials and Methods. Three purified HSSB preparations,
untreated, phosphorylated, or mock-treated (unphosphorylated),
were compared for their ability to support SV40 DNA replication.
tion of HeLa cytosolic extract contains the host replication
factors with the exception of HSSB. The supplementation of
this AS fraction with HSSB and T antigen results in efficient
SV40 DNA synthesis. As shown in Fig. 2B, both unphosphor-
ylated and phosphorylated forms of HSSB were equally active
in supporting SV40 DNA synthesis with the 35-65% AS
fraction.
The rate of SV40 DNA replication in the monopolymerase
reaction in the presence of the different HSSB preparations
was identical, and no change in the phosphorylation state of
the p34 subunits of HSSB was detected after incubation in the
monopolymerase system (data not shown). Consistent with
this, we observed no differences between the phosphorylated
and unphosphorylated forms of HSSB in their ability to bind
ssDNA (data not presented). We conclude from these exper-
iments that the phosphorylation status of HSSB has no effect
on the SV40 DNA replication system.
Excision Repair with Phosphorylated HSSB. Using an in
vitro system for nucleotide excision repair, we tested the effect
of phosphorylation on DNA repair. In this system both exci-
sion (6) and repair synthesis (4) are dependent on HSSB. Fig.
3 shows the level of excision of a cholesterol adduct as a
function of HSSB concentration. At low HSSB concentration
it appears that unphosphorylated HSSB was more active;
however, at high concentrations the trend was reversed. These
results indicate that phosphorylation either has no or only a
moderate effect on excision repair. However, the observed
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FIG. 3. Excision repair with unphosphorylated (U-HSSB; mock-
treated) or phosphorylated (P-HSSB) HSSB in a reconstituted system
as a function of HSSB concentration. The indicated amounts of HSSB
were added to the reconstituted repair system. The excision reaction
was carried out for 45 min at 30°C. (A) Autoradiographic analysis of
excision products. Lane 1, no addition; lanes 2, 3, and 4, 0.2, 0.4, and
0.8 jug of unphosphorylated (mock-treated) HSSB, respectively; lanes
5, 6, and 7, 0.2, 0.4, and 0.8 ,ug of phosphorylated HSSB, respectively.
The number 28 indicates the nucleotide length of the major excision
product. (B) Quantitative analysis of excision products. The excision
products were analyzed by using a PhosphorImager (Molecular Dy-
namics).
differences in either direction were within experimental vari-
ability. Hence we conducted kinetic experiments to assess the
effect of phosphorylation on excision.
Fig. 4 represents excision kinetics by the excision system with
purified proteins. Again, the two forms of HSSB showed
essentially the same activity. At later time points (45 and 60
min), the unphosphorylated form appears to be 10-30% more
active, an observation we attribute to experimental variation.
Phosphorylation Status of HSSB During and After Repair.
The excision repair system we used was reconstituted from
highly purified proteins. However, with the exception of
xeroderma pigmentosum A, all of the other factors were
purified from HeLa cells. It was conceivable that these purified
proteins might be contaminated with sufficient quantities of
cdk-cyclin A complex and DNA-PK to phosphorylate the
nominally unphosphorylated HSSB in our reaction mixtures.
Therefore, the phosphorylation status of HSSB was tested
after an excision reaction by performing an immunoblot
analysis (Fig. 5) or silver staining. No change was seen in the
phosphorylation status of either unphosphorylated or phos-
phorylated HSSB after the repair reaction. Thus, we conclude
that the phosphorylation status of HSSB has no bearing in its
role in nucleotide excision repair.
4638 Biochemistry: Pan et al
Proc. Natl. Acad. Sci. USA 92 (1995) 4639
A U-HSSB P-HSSB
0 15 30 45 60 0 15 30 45 60 (min)
1 2X3 4 5 6 7I8 - 28
1 2 3 4 5 6 7 8 9 10
0 20 40 60 80
Time, min
FIG. 4. Kinetics of excision repair with unphosphorylated (mock-
treated) or phosphorylated HSSBs in a reconstituted system. Either
unphosphorylated (U-HSSB; mock-treated) or phosphorylated (P-
HSSB) HSSB (0.4 t,g) was added to the reconstituted repair system.
The excision reaction was conducted at 30°C as indicated. (A) Auto-
radiographic analysis of excision products. The number 28 indicates
the nucleotide length of the major excision product. (B) Quantitative
analysis of the yield of excision products.
DISCUSSION
In E. coli damage to DNA by a variety of agents elicits the SOS
response (28, 29). An essential component of this response is
inhibition of the cell division cycle coupled to an increase in
DNA repair activity; the net result is a rapid elimination of
DNA lesions before resumption of the cell cycle. Recently,
several phenomena reminiscent of the SOS response have
been described in mammalian cells. (i) It has been found that
after radiation damage (UV or x-ray) the p34 subunit of HSSB
becomes hyperphosphorylated (14, 15), and furthermore it was
reported that cell extracts from UV-irradiated cells, which
contained mostly phosphorylated HSSB, were unable to sup-
port SV40 replication. Thus, it was proposed that phosphor-
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FIG. 5. Effect of excision repair reaction on HSSB phosphoryla-
tion. Unphosphorylated (U-HSSB; mock-treated) or phosphorylated
(P-HSSB) HSSB was incubated for 45 min at 30°C under the excision
(Exc) repair reaction conditions and then analyzed by SDS/PAGE and
Western blot with a monoclonal antibody against the 34-kDa subunit
of HSSB.
creating a status similar to that during the SOS response in E.
coli (15). (ii) It has been found that p21 (Cip 1, WAF 1, or Sdi
1), induced by DNA damage as a result of transcriptional
activation by p53 (30, 31), binds to PCNA directly and that this
complex of PCNA is inactive in SV40 DNA replication (16, 17)
but has normal activity in nucleotide excision repair (18, 19).
This response was also proposed to help genomic stability and
cell survival by allowing repair to proceed (at a normal rate)
while replication is inhibited. (iii) Finally, it has also been
reported that the growth arrest and DNA damage-inducible
Gadd45 protein inhibits cell growth (32) while simultaneously
stimulating excision repair by about a factor of 3 (33).
While each of the proposed damage response reactions
listed above makes sense from a teleological viewpoint, they
must be subjected to rigorous experimental tests before we
assume that mammalian cells have an SOS response function-
ally homologous to the bacterial SOS response. Indeed the
experimental results reported in this paper do not support the
notion that phosphorylation of HSSB plays a direct role in
dissociating repair from replication as a means for cells to
maintain genomic stability after sustaining DNA damage.
In light of the results presented here, it might be asked
whether phosphorylation of HSSB has any physiological rel-
evance. Three recent studies bear on this question. Pan et aL
(23) reported that the p34 subunit of HSSB was phosphory-
lated in two steps: first by cdk-cyclin A and then by DNA-PK.
Furthermore, it was found that p21 (Cip 1, WAF 1, or Sdi 1)
prevented HSSB p34 phosphorylation entirely in cyclin A-ac-
tivated G1 extracts by inhibiting cdk-cyclin A activity, which
performed the first phosphorylation reaction. Henricksen and
Wold (34) reported that HSSB p34 with serine -> alanine
substitutions at Ser-23 and Ser-29 (serine cdc2 kinase consen-
sus phosphorylation sites) had normal DNA-binding activity,
had normal replication activity in a partially purified system,
and became phosphorylated under replication conditions.
Finally, Brush et al (35) showed that even though DNA-PK
was required for SV40 DNA replication-dependent phosphor-
ylation of HSSB p34 in cell-free extracts (36), depletion of the
kinase activity with DNA-PK antibodies had no effect on DNA
replication. These studies, which identified some sites and the
mechanism of HSSB phosphorylation, do not directly address
the issue of whether or not phosphorylated HSSB is active in
replication or repair. In contrast, the data presented in this
paper provide direct evidence that the phosphorylation status
of the HSSB p34 subunit plays no direct role either in SV40
DNA replication or in nucleotide excision repair. It has been
suggested that DNA replication intermediates, such as a
replication fork, act as a cofactor for DNA-PK to promote
phosphorylation of HSSB and that the phosphorylated form of
HSSB initiates a signaling pathway that prevents cell cycle
progression while replication or repair intermediates exist
(35). Further studies are needed to test this model.
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